Mean age (years)±SD | 54.9±11.3 | 60.0±10.4 | 0.014 |
Male n, (%) | 99 (70.7) | 41 (58.6) | 0.078 |
Race n, (%) | | | 0.949 |
White | 74 (52.9) | 37 (52.9) | |
African American | 63 (45.0) | 31 (44.3) | |
Other | 3 (2.1) | 2 (2.9) | |
Mean weight (kg) ±SD | 104.1±29.7 | 96.2±27.1 | 0.062 |
Mean hemoglobin A1c (%) ±SD** | 9.5±2.7 | 9.3±2.4 | 0.759 |
Chronic kidney disease | | | 0.503 |
Stage 2 n, (%) | 3 (2.1) | 1 (1.4) | |
Stage 3 n, (%) | 19 (13.6) | 12 (17.1) | |
Stage unknown n, (%) | 12 (8.6) | 7 (5.0) | |
Median SCr (mL/min) at antibiotic initiation (IQR) | 1.10 (0.90–1.49) | 1.06 (0.77–1.51) | 0.434 |
Mean Charlson Comorbidity Index ±SD | 3.75±1.6 | 4.2±1.5 | 0.042 |
Primary admission service: ICU n, (%) | 9 (6.4) | 3 (4.3) | 0.755 |
Sepsis criteria n, (%) | 11 (7.9) | 5 (7.1) | >0.999 |
Hypotension on admission n, (%) | 26 (18.6) | 8 (11.4) | 0.185 |
Osteomyelitis n, (%) | 99 (70.7) | 38 (54.3) | 0.018 |
Beta-Lactam or vancomycin in past 90 days n, (%) | 31 (22.1) | 23 (32.9) | 0.094 |
Vancomycin loading dose given n, (%) | 44 (31.4) | 19 (27.1) | 0.523 |
Mean vancomycin loading dose (mg/kg) ±SD | 19.0±3.9 | 18.2±2.6 | 0.405 |
Mean vancomycin trough (mg/L) prior to AKI±SD | 26.1±10.6 | 30.5±6.1 | 0.367 |
Nephrotoxic agent within 72 hours n, (%) | 107 (76.4) | 48 (68.6) | 0.383 |
Number of nephrotoxic agents | | | 0.154 |
One n, (%) | 67 (47.9) | 25 (35.7) | |
Two to three n, (%) | 22 (15.7) | 14 (20.0) | |
Three or more n, (%) | 14 (10.0) | 9 (12.9) | |
Infectious diseases consult n, (%) | 98 (70.0) | 38 (54.3) | 0.025 |
Nephrology consult n, (%) | 27 (19.3) | 2 (2.9) | 0.001 |
Pharmacy pharmacokinetic consult n, (%) | 138 (98.6) | 65 (92.9) | 0.043 |